In this setting, heterozygous C3 variants that impair pegcetacoplan binding could make the PNH patient exceptionally susceptible to intravascular hemolysis crises, particularly during acute-phase responses or infections that transiently increase C3 synthesis. The gene discussed is C3; the disease is hemolysis.